Flumexadol is primarily used in research settings for its potential analgesic properties. It acts as a centrally acting pain reliever with activity on opioid pathways, though it is not associated with typical opioid side effects such as respiratory depression or high addiction potential in studied models. Due to its unique mechanism, it has been investigated for use in chronic pain management, especially in cases where traditional opioids are ineffective or pose too great a risk. It may also have applications in the study of serotonin and dopamine modulation, making it relevant in neuropharmacology research. Flumexadol is not approved for clinical use in most countries and remains mainly a tool compound in preclinical studies.